Skip to main content
. 2021 Jul 18;13(1):209–219. doi: 10.1007/s13340-021-00524-3

Table 1.

Clinicodemographic subjects characteristics in the overall cohort and by treatment group

All subjects FW EHW p
Age (y) 68.0 (63.0, 75.0) 68.0 (57.5, 75.0) 66.0 (64.5, 72.5) 0.802
Sex [M/F (Male %)] 25/20 (55.6) 12/10 (54.5) 13/10 (56.5) 1.000
BMI (kg/m2) 26.8 + 4.4 27.7 + 5.0 25.9 + 3.8 0.193
HbA1c (mmol/mol) 45.8 + 4.9 44.9 + 4.9 46.6 + 4.9 0.264
HbA1c (%) 6.41 + 0.50 6.33 + 0.52 6.50 + 0.48 0.264
Duration of diabetes (y) 10 (7, 20) 10 (5, 18) 12 (10, 21) 0.093
Systolic BP (mmHg) 133.6 + 16.7 134.5 + 15.1 132.8 + 18.3 0.733
Diastolic BP (mmHg) 76.6 + 11.9 76.2 + 12.3 76.9 + 11.7 0.859
HR (BPM) 78.8 + 13.5 76.9 + 15.2 80.5 + 11.8 0.380
HOMA-IR 1.49 (0.99, 2.48) 1.61 (1.33, 2.53) 1.06 (0.89, 2.07) 0.171
HOMA-β 44.3 (27.8, 65.2) 46.2 (27.9, 68.5) 42.7 (27.8, 59.0) 0.708
OGTT-G-0 (mmol/L) 5.8 (5.4, 6.8) 5.9 (5.4, 6.9) 5.8 (5.3, 6.6) 0.708
OGTT-G-120 (mmol/L) 13.3 + 4.4 13.4 + 3.9 13.2 + 4.9 0.919
OGTT-G-AUC 24.1 + 4.8 24.1 + 4.6 24.2 + 5.0 0.943
OGTT-I-0 (pmol/L) 40.3 (25.0, 58.3) 44.4 (35.6, 64.9) 29.9 (24.0, 55.9) 0.146
OGTT-I-120 (pmol/L) 209.7 (113.2, 340.3) 192.4 (121.2, 373.1) 216.0 (109.7, 295.5) 0.768
OGTT-I-AUC 296.6 (191.7, 454.2) 333.1 (191.6, 457.7) 289.3 (213.1, 427.4) 0.744
OGTT-[GxI]-AUC 6932 (4746, 9852) 7256 (4792, 9483) 6932 (4518, 9916) 0.831
Glycoalbumin (%) 15.9 + 2.0 15.7 + 1.5 16.1 + 2.3 0.421
Total cholesterol (mmol/L) 5.03 + 0.79 4.75 + 0.66 5.30 + 0.83 0.018
HDL cholesterol (mmol/L) 1.29 (1.14, 1.60) 1.25 (1.09, 1.64) 1.34 (1.16, 1.59) 0.625
Triglyceride (mmol/L) 1.18 + 0.46 1.15 + 0.51 1.21 + 0.42 0.684
S-uric acid (µmol/L) 339 (274, 404) 366 (293, 422) 303 (268, 348) 0.084
U-uric acid (mmol/mol Cre) 339 + 120 374 + 114 305 + 117 0.049
S-lactate (mmol/L) 1.21 + 0.44 1.25 + 0.39 1.17 + 0.48 0.539
S-pyruvate (µmol/L) 70.4 (57.9, 88.6) 74.4 (66.4, 88.6) 60.2 (55.6, 87.4) 0.280
S-MG (nmol/L) 143 (112, 199) 133 (114, 161) 144 (111, 210) 0.638
U-MG (µmol/mol Cre) 107 (89, 139) 107 (91, 138) 108 (88, 142) 0.981
U-pH 6.0 (5.5, 7.0) 6.0 (5.5, 6.9) 6.0 (5.5, 6.8) 0.935
U-8-OHdG (μmol/mol Cre) 3.0 (2.3, 3.5) 3.1 (2.3, 3.7) 3.0 (2.4, 3.3) 0.790
d-ROMs (U CARR) 291.4 + 39.8 296.1 + 37.6 287.0 + 42.2 0.453
BAP (μmol/L) 2077 + 171 2124 + 141 2034 + 187 0.078
S-creatinine (µmol/L) 62.8 (55.7, 78.7) 62.3 (56.4, 75.8) 71.6 (56.6, 88.0) 0.352
eGFR (mL min-1 [1.73 m]−2) 67.5 + 19.9 70.5 + 19.2 65.1 + 20.6 0.441
ACR (g/mol Cre) 0.82 (0.48, 1.95) 0.88 (0.54, 2.82) 0.66 (0.40, 1.43) 0.481
BUN (mmol/L) 5.39 (4.39, 6.96) 5.60 (4.42, 6.78) 5.28 (4.41, 7.07) 0.973
UUN (mol/mol Cre) 31.9 (29.5, 37.9) 33.7 (30.1, 40.0) 31.1 (26.8, 36.3) 0.284
BNP (ng/L) 20.4 (11.1, 49.3) 30.4 (10.6, 51.8) 19.6 (11.9, 37.2) 0.549
S-Na+ (mmol/L) 141 + 2 141 + 2 141 + 1 0.170
S-K+ (mmol/L) 4.3 (4.2, 4.8) 4.3 (4.2, 4.8) 4.3 (4.2, 4.7) 0.945
S-Cl (mmol/L) 104.3 + 2.5 105.0 + 2.4 103.7 + 2.5 0.083
U-Na+ (mol/mol Cre) 19.1 (11.9, 32.1) 18.4 (9.3, 38.2) 19.1 (13.0, 28.5) 0.991
U-K+ (mol/mol Cre) 4.04 (3.37, 5.87) 4.68 (3.51, 6.33) 3.86 (3.14, 5.60) 0.194
U-Cl (mol/mol Cre) 18.0 (11.8, 31.7) 17.5 (12.0, 39.2) 19.6 (12.5, 28.2) 1.000
Red blood cells (1012/L) 4.47 + 0.47 4.51 + 0.56 4.43 + 0.38 0.592
Hematocrit (%) 42.1 + 4.0 42.4 + 4.5 41.7 + 3.6 0.569
Hemoglobin (g/L) 138 + 15 139 + 17 136 + 13 0.550
White blood cell (109/L) 5.60 + 1.36 5.28 + 1.23 5.91 + 1.43 0.119
Platelet (109/L) 242 (205, 275) 225 (195, 265) 267 (213, 327) 0.061
ALT (µkat/L) 0.33 (0.23, 0.42) 0.39 (0.30, 0.59) 0.30 (0.23, 0.33) 0.011

The values are expressed as the mean + SD or median (interquartile range)

FW filtered water, EHW electrolyzed hydrogen-rich water, HR heart rate, BPM beats per minute, HOMA-IR HOMA-Insulin resistance, HOMA-β HOMA beta-cell, OGTT oral glucose tolerance test, G glucose, 0 at 0 min, 120 at 120 min, I insulin, S serum, U urinary, MG methylglyoxal, 8-OHdG 8-hydroxy-2′-deoxyguanosine, d-ROMs diacron-reactive oxygen metabolites, U CARR Carratelli units, BAP biological antioxidant potential, ACR albumin creatinine ratio, BUN blood urea nitrogen, UUN urine urea nitrogen, ALT alanine transaminase